Pharmaceuticals,Pharmaceuticals sector projects by Pharmaceutical Industries Limited in
Project Information
5093
Pharmaceutical Industries Limited
Sun Pharmaceutical Industries And Glenmark Generics Have Got Approval From US Health Regulator To Sell Generic Versions Of Nervous System Disorder Treatment Drug Riluzole. The Approvals Were Given For Generic Riluzole Oral Tablets In The Strength Of 50 Mg. Riluzole Is Indicated For Treatment Of Amyotrophic Lateral Sclerosis. As Per IMS Health Sales Data For The 12 Month Period Ended March 2013, Riluzole Had Garnered Sales Of USD 64 Million In The US Market. Sun Pharmaceutical Industries Limited Is An Indian Global Pharmaceutical Company.
Project Value
Refer document
Pre Project Activities Underway
Not Specified
India
Pharmaceuticals,Pharmaceuticals
Disclaimer :
We takes all possible care for accurate & authentic tender information, however Users are requested to refer Original source of Tender Notice / Tender Document published by Tender Issuing Agency before taking any call regarding this tender.
